These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 232084)

  • 1. Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.
    Sullivan JM; Ginsburg BA; Ratts TE; Johnson JG; Barton BR; Kraus DH; McKinstry DN; Muirhead EE
    Hypertension; 1979; 1(4):397-401. PubMed ID: 232084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of converting enzyme inhibitors in diagnosis of renovascular hypertension. I. Comparison of the effect of angiotensin converting enzyme inhibition on blood pressure and plasma renin activity in patients with primary hypertension and renovascular hypertension].
    Posadzy-Małaczyńska A
    Przegl Lek; 1997; 54(5):314-9. PubMed ID: 9380805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
    Ueda Y; Honda M; Hatano M
    Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antihypertensive effect of captopril in severe essential, renovascular, renal and transplant renovascular hypertension.
    Schwietzer G; Oelkers W
    Klin Wochenschr; 1982 Aug; 60(16):839-46. PubMed ID: 6752559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of angiotensin converting enzyme inhibitors in the diagnosis of renovascular hypertension. II. Comparison of the effect of angiotensin converting enzyme inhibition on reno-scintigraphic curves with DTPA in patients with essential and renovascular hypertension].
    Posadzy-Małaczyńska A
    Przegl Lek; 1997; 54(7-8):524-8. PubMed ID: 9480462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
    Waeber B; Gavras I; Brunner HR; Cook CA; Charocopos F; Gavras HP
    Am Heart J; 1982 Mar; 103(3):384-90. PubMed ID: 6278905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the acute effect of a converting enzyme inhibitor, captopril, in normal and hypertensive subjects].
    Mimran A; Laroche B; Targhetta R; Roumieux JL
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():61-5. PubMed ID: 6794529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
    Hashimoto H; Hiwada K; Kokubu T
    Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
    Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
    Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension.
    Ideishi M; Sasaguri M; Ikeda M; Arakawa K
    Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between renovascular and essential hypertension by means of changes in single kidney 99mTc-DTPA clearance induced by angiotensin-converting enzyme inhibition.
    Pedersen EB; Jensen FT; Eiskjaer H; Hansen HH; Jensen JD; Jespersen B; Madsen B; Nielsen HK; Sørensen SS
    Am J Hypertens; 1989 May; 2(5 Pt 1):323-34. PubMed ID: 2655658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of moderate to severe hypertensive patients with an orally active converting-enzyme inhibitor.
    Prins EJ; Donker AJ; Hoorntje SJ; Leenen FH; van der Hem GK
    Proc Eur Dial Transplant Assoc; 1979; 16():603-9. PubMed ID: 232914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.
    MacGregor GA; Markandu ND; Roulston JE; Jones JC
    Br Med J; 1979 Nov; 2(6198):1106-9. PubMed ID: 229941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term captopril treatment in moderate to severe hypertension.
    Santucci A; Aguglia F; De Mattia G; Ficara C; Balsano F
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):77S-79S. PubMed ID: 6753908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats.
    Antonaccio MJ; Rubin B; Horovitz ZP; Laffan RJ; Goldberg ME; High JP; Harris DN; Zaidi I
    Jpn J Pharmacol; 1979 Apr; 29(2):285-94. PubMed ID: 231700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.